Global Macro
The three major futures indexes rose and fell before the market
Biden called on Americans to be vaccinated against Omicron and will distribute 500 million kits
U.S. President Joe Biden said the spread of Omicron would mean a large number of breakthrough infections and was considering lifting travel restrictions on southern African countries where the strain was first discovered. Biden also announced emergency measures to deal with the spread of Omiljung this winter, including government procurement and free delivery of 500 million household RAPID TEST kits for the new coronavirus to the public, which are expected to be operational next January. As for the risks faced by a quarter of U.S. adults who have not yet been vaccinated, Biden said in a frightening tone: "Your choice may be the difference between life and death." Biden also instructed the secretary of defense to prepare to dispatch 1,000 military medical professionals, such as military doctors and nurses, to local hospitals to help and support hospitals that are already overwhelmed, as needed.
After being stirred up, the Democratic Party also wants to save 2 trillion stimulus
According to the Financial Times, Biden said on Tuesday he could find a way to reach a deal with Senator Manchin. Biden sought to de-escalate tensions, saying "Senator Manchin and I will make a difference."
Democratic Senator Manchin, who holds key votes, again made it clear in a press briefing on Sunday that he would oppose support for the bill, followed by White House press secretary Jen Psak and Congressional Progressive Caucus president Pramila Jayapal both issuing statements accusing Manchin of "breaking promises." Schumer insisted Monday that Manchin's intervention would not "stop" Democrats from "continuing to try to find a way forward," adding that lawmakers should expect to vote on the bill in early 2022. The Senate held an intense conference call Tuesday night.
U.S. stocks reverse the trend of continuous decline! Most heads: The S&P 500 is expected to reach a new high next year, with a target of 5330 points by the end of the year
Tom Lee, former chief equity strategist at JPMorgan Chase, believes that the S&P 500 will rise for the fourth consecutive year in 2022, rising at least 11% to 5100 points, but will fall at least 10% in the first half of the year. Lee wrote in a note to clients on Tuesday that he expects the first half of the year to be bumpy, with the potential to fall by at least 10 percent. This potential sell-off could be driven by a surge in COVID-19 cases, lingering "supply chain problems" and investor concerns about the hawkish Fed. But after that, as inflation flattens, labor tensions ease, and the "Fed's Band-Aid" is removed (completed in its tapering), the stock market should go into a risk-chasing upward pattern and set a record in the second half of 2022. These factors, combined with an increase in earnings per share of S&P 500 constituents, by 8% to $250, form his underlying scenario for the index to reach 5100 by the end of next year. Lee concludes: "Economic growth remains strong, [which means] the stock market is resilient."
More than 930 billion yuan, this year's global ship investment doubled
The international shipping market has recovered strongly, with global ship investment increasing significantly this year. On December 22, according to the latest data disclosed by Clarkson Research in the United Kingdom, the total global ship investment this year has reached 147 billion US dollars (about 936.6 billion yuan), nearly double the investment amount of 74 billion US dollars last year. Among them, the total investment in newbuilding reached 103 billion US dollars, an increase of about 106% over the same period last year, a new high in the past eight years. With less than two weeks left this year, Clarkson predicts that the final ship investment for the year is expected to reach its highest level since the financial crisis, unchanged from $159 billion in 2013 and about 50% higher than the annual average of $100 billion in 2017-2019.
The U.S. government expects to receive 4 million courses of COVID-19 treatments by the end of January
According to local media sources quoted by government sources on Wednesday morning, the U.S. government expects to receive a total of 4 million courses of COVID-19 treatment by the end of January next year. Merck and Pfizer will provide 3 million and 250,000 courses of ORAL COVID-19 respectively, in addition to AstraZeneca's preventive therapy. Previously, it was reported that the US FDA would officially approve merck and Pfizer's new coronavirus oral drugs as soon as Wednesday.
The UK released data concluding that the Aumechjung variant caused milder symptoms than those of Delta
Later on Wednesday, the UK's Health Security Agency reportedly said its data showed that the illness caused by Omicron was not as severe as Delta. Until this month, Delta had been the UK's main strain. However, the UK Health Safety Agency still warns that excessively high numbers of infections may still lead to a sharp increase in hospitalizations at some point. However, neither the United Kingdom nor South Africa, where Aumechjong was first discovered, has not yet occurred. However, fearing a labour shortage due to the pandemic, the UK government has now reduced the duration of self-isolation from 10 days to 7 days.
New research in South Africa found that the risk of hospitalization for infection with Aomi Kerong is 80% lower than other strains.
According to a study published by the National Institute of Infectious Diseases in South Africa, among patients infected with the new coronavirus during the current fourth round of the epidemic, those infected with the Omikejong variant are 80% less likely to be hospitalized than those infected with other strains. Authors such as scientists Nicole Walter and Cheryl Cohen point out that once hospitalized, the risk of severe illness is similar to that of other strains. They noted that those infected with the Opmecreon virus were 70% less likely to be severely ill than those infected with the Delta strain in South Africa from April to November.
Grab the world's first place again! Israel began a fourth dose of the vaccine, targeting people over the age of 60
The Israeli government announced on Tuesday (December 21) that it will provide a fourth dose of covid-19 vaccine to people over the age of 60 to cope with the rapid spread of the current Omikejung variant virus. This is the country's first vaccination at the beginning of the year, and it is once again ahead of the rest of the world in terms of vaccination schedule. Israeli Prime Minister Naftali Bennett quickly welcomed the decision after a panel of experts from the Israeli Ministry of Health recommended a fourth dose of the vaccine.
Hot news
Star tech stocks fell mostly before market
Throw this one away? Musk said he had sold enough Tesla stock
I sold enough stock to reach the level of selling about 10% of my shares, plus exercising options, and I tried to be as straightforward as possible at this point.
Elon Musk said in an interview with the satirical website Babylon Bee.
As of press time, Tesla is up more than 3% before the market.
The U.S. FDA plans to authorize Merck and Pfizer for oral use of covid-19 drugs
The government hopes that these drugs will further reduce hospitalization rates and mortality rates than they did last year. The U.S. government has ordered 10 million courses of Pfizer and 3 million courses of Merck. According to the available clinical data, the effect is not good. It is worth noting, however, that so far, there have been no deaths among patients treated with these drugs.
As of press time, the anti-epidemic concept stocks have risen and fallen.
U.S. regulators have launched an investigation into Tesla's car game features
The National Highway Traffic Safety Administration issued a statement on Wednesday saying it launched an investigation into Tesla's touchscreen game feature, involving 580,000 cars of multiple models, and Tesla also named the feature "Passenger Play." Regulators believe this feature can cause driver distractions and cause accidents. It is worth mentioning that until the feature is launched at the end of 2020, Tesla cars can only use the game function when parking.
NovaVac Pharma conducted an extended clinical trial of the new crown vaccine enhanced injection Phase 3
Apple rating was adjusted to the highest! Join the "Top Credit Rating Club"
International rating agency Moody's on Tuesday will be $100 for Apple (AAPL. US)$ long-term credit rating was upgraded to the highest Aaa rating, and the outlook is stable. The agency expects the tech giant to maintain strong liquidity and profitability for years to come. After the adjustment, Apple has also joined the ranks of the "top credit evaluation club" of Microsoft and other companies.
The upgrade of Apple's rating to Aaa reflects the company's extraordinary liquidity, strong earnings (which we expect to continue to grow over the next 2 to 3 years), and very strong business conditions.
Moody's analyst Raj Joshi said in a newly released statement,
Moody's expects Apple's operating income to grow at a mid-single-digit rate over the next 12-24 months, with growth in the services, wearables and iPhone categories leading the way. Also, since the iPhone still accounts for more than 50 percent of Apple's revenue, moving to higher-priced 5G smartphones and services should help make a profit.
The State Administration for Market Regulation conditionally approved SK Hynix's acquisition of Intel's NAND business
The State Administration for Market Regulation (SAMR) issued an announcement on December 22, deciding to attach restrictive conditions to approve SK Hynix's acquisition of $Intel (INTC. US) $ part of the business. After the concentration, the entity shall fulfill the following obligations and shall not supply PCIe enterprise-class SSD products and SATA enterprise-class SSD products to the domestic market in China at unreasonable prices. Continue to expand production of PCIe enterprise SSD products and SATA enterprise SSD products for five years from the effective date. No written or verbal agreement, decision or other concerted action (including implied synergy) with its primary competitor in China that excludes or restricts competition is not entered into with respect to the selling price, volume or volume of sales.
Italian prosecution reports show boeing suppliers supplying defective accessories for years on end
According to media reports, Italian prosecutors said in a preliminary investigation report that local parts supplier MPS (renamed Processi Speciali after bankruptcy) provided Boeing with more than 4,000 defective parts between 2016 and 2021, mainly for 35 $Boeing (BA. US) $787 of the airframe of the airliner. The supplier also supplies spare parts for the Boeing 767 transport aircraft.
Japan said it was difficult to evaluate new drugs for Bojam Alzheimer's disease
A subsidiary committee of Japan's Ministry of Health, Labor and Welfare issued a statement on Wednesday saying that the listing application for Aduhelm, a new drug for Alzheimer's disease in Japan and the United States $Bogen (BIOGEN), made it difficult for the committee to judge the effect of the drug due to the inconsistent results and clinical effects of its global Phase III trial. Japan also said that if the two companies submit further data in the future, they will also re-evaluate.
Citi: Bullish on Apple's development prospects, raised the target price to $200
Citi analyst Jim Suva reiterated Apple's "buy" rating, raising its price target to $200 from $170. Analysts pointed out that after the market share growth in 2021, the demand for Apple products and services should remain "elastic" in fiscal 2022. Analysts believe that Apple's current market capitalization does not fully reflect the company's achievements in the field of new products, and the stock price should change as the company's VR/AR headsets may be launched next year. In addition, analysts said that while the regulation of Apple is a hidden danger, it brings "news risk, not fundamental risk", and any recent correction in Apple's stock price will be a buying opportunity.
Focus on Chinese stocks
Popular Chinese stocks were lower before market hours
Station B invests in Mingliang Culture, which includes the sale of toys and amusement supplies
According to the Tianyancha App, suzhou Mingliang Culture Technology Co., Ltd. has undergone industrial and commercial changes recently, adding $Bilibili (BILI. US)$ affiliate Shanghai Bilibili Technology Co., Ltd. is a shareholder, and the registered capital of the company has increased to 6.25 million yuan. Suzhou Mingliang Culture Technology Co., Ltd. was established in March 2021, the legal representative and suspected actual controller is Zhou Mingxi, the business scope includes digital cultural creative content application services, toys, animation and amusement supplies sales; general cargo warehousing services.
TOP20 pre-market turnover of US stocks
U.S. Macro Chronicle Reminder:
Specific arrangements for the release of US macro data on December 22
21:30 U.S. Q3 Real GDP Annualized QTR (2.1% Forecast vs 2.1% Previous)
21:30 US Q3 GDP Deflator (5.9% Forecast vs 5.9% Previous)
23:00 US December Consultative Council Consumer Confidence Index (Forecast 110.8, Previous 109.5)
23:00 ANNUALIZED NOVEMBER MONTHLY OF US HOME SALES (previous: 0.8%)
23:00 Total annualized U.S. home sales in November (Forecast 6.52 million units, previous value 6.34 million units)
23:30 U.S. EIA Crude Inventories Change for the Week (Forecast -2.633 million barrels, previous -4.584 million barrels)
23:30 U.S. EIA Cushing Crude Inventories Change for the Week (Previous Value: 1.294 million barrels)
Changes in key global indicators
The latest value of API crude oil inventories in the US for the week was -3.67 million barrels, compared with -815,000 barrels in the previous week.
The latest U.S. current account for the third quarter was -$214.8 billion, compared to -$198.3 billion (revised).
Edit/irisz
Risk Warning: The views of the authors or guests shown above have their own specific positions, and investment decisions need to be based on independent thinking. Futu Holdings will endeavour, but cannot guarantee, the accuracy and reliability of the above contents and will not be liable for any loss or damage arising from any inaccuracies or omissions.